TG THERAPEUTICS, INC. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2021-06-18

Reporting Person: Power Sean A (CFO, Secretary and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-18	COMMON STOCK	A	25000	—	Acquired	653448	Direct

Footnotes

F1: Reflects a grant of restricted shares relating that will vest in according to the following schedule: 50% on January 1, 2022, and 25% on each of January 1, 2023 and 2024.

F2: Includes shares of restricted Common Stock, which are subject to vesting and 107,500 shares of TG Therapeutics stock issuable pursuant to stock options that are currently exercisable or exercisable within 60 days of this filing.